Highmark Health ended 2025 deep in the red, posting roughly a $674 million operating loss, even as its hometown hospital system, Allegheny Health Network, quietly returned to the black. AHN logged about $90 million in operating income for the year, a sharp contrast that underlines how rising claims and specialty drug costs are hammering the insurance side while hospital volumes recover.
The full-year breakdown comes from the Pittsburgh Business Times, which reported Highmark’s consolidated operating loss for calendar 2025 at $674 million and AHN’s operating income at roughly $90 million. The outlet said most of the red ink came from the insurer businesses, which faced higher-than-expected use of services, citing company documents and statements.
What’s Behind the Red Ink?
Inside Highmark’s C-suite, the culprits are not exactly a mystery. Company leaders have repeatedly pointed to sustained utilization of medical services and elevated pharmacy costs as the main drags on performance at the health plans.
In a December release, Highmark Health said strong results at Allegheny Health Network and other diversified businesses were outweighed by claims pressure in its insurance operations. The company also noted it held about $11.9 billion in cash and investments as of Sept. 30, a signal that its balance sheet still has some cushion even as operations struggle.
Industry Headwinds: Utilization and Drug Costs
Highmark’s problems do not exist in a vacuum. Analysts say the insurer is riding the same choppy waters as peers across the country: more people using more care, and pharmacy bills that keep pushing higher…